324 related articles for article (PubMed ID: 19739256)
1. Serum golgi phosphoprotein 2 level: a better marker than alpha-fetoprotein for diagnosing early hepatocellular carcinoma.
Li X; Wu K; Fan D
Hepatology; 2009 Nov; 50(5):1682. PubMed ID: 19739256
[No Abstract] [Full Text] [Related]
2. Serum Golgi Phosphoprotein 2 level: a better marker than alpha-fetoprotein for diagnosing early hepatocellular carcinoma.
Li X; Wu K; Fan D
Hepatology; 2009 Jul; 50(1):325. PubMed ID: 19492428
[No Abstract] [Full Text] [Related]
3. Alpha-fetoprotein and serum golgi phosphoprotein 2 are equally discriminative in detecting early hepatocellular carcinomas.
Riener MO; Stenner F; Liewen H; Hellerbrand C; Bahra M; Kristiansen G
Hepatology; 2009 Jul; 50(1):326. PubMed ID: 19496179
[No Abstract] [Full Text] [Related]
4. [Significance of Golgi glycoprotein 73, a new tumor marker in diagnosis of hepatocellular carcinoma: a primary study].
Mao YL; Yang HY; Xu HF; Sang XT; Lu X; Yang ZY; Zhang JC; Zhong SX; Huang JF; Zhang HB
Zhonghua Yi Xue Za Zhi; 2008 Apr; 88(14):948-51. PubMed ID: 18756964
[TBL] [Abstract][Full Text] [Related]
5. GP73, a resident Golgi glycoprotein, is a novel serum marker for hepatocellular carcinoma.
Marrero JA; Romano PR; Nikolaeva O; Steel L; Mehta A; Fimmel CJ; Comunale MA; D'Amelio A; Lok AS; Block TM
J Hepatol; 2005 Dec; 43(6):1007-12. PubMed ID: 16137783
[TBL] [Abstract][Full Text] [Related]
6. Golgi protein 73 (GOLPH2) is a valuable serum marker for hepatocellular carcinoma.
Mao Y; Yang H; Xu H; Lu X; Sang X; Du S; Zhao H; Chen W; Xu Y; Chi T; Yang Z; Cai J; Li H; Chen J; Zhong S; Mohanti SR; Lopez-Soler R; Millis JM; Huang J; Zhang H
Gut; 2010 Dec; 59(12):1687-93. PubMed ID: 20876776
[TBL] [Abstract][Full Text] [Related]
7. [Significance of serum golgi protein 73 (GP73), alpha-fetoprotein (AFP) and lectin-reactive alpha-fetoprotein (AFP-L3) expresssion in primary hepatic carcinoma].
Xu WF; Fei YM; Zhou JK; Shen HJ; Chen XF; Lv QQ; Ding YY
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2011 Aug; 25(4):286-8. PubMed ID: 22097609
[TBL] [Abstract][Full Text] [Related]
8. [Molecular markers for early diagnosis of hepatocellular carcinoma].
Yao DF
Zhonghua Gan Zang Bing Za Zhi; 2004 Aug; 12(8):492. PubMed ID: 15329213
[No Abstract] [Full Text] [Related]
9. Clinical course of chronic hepatitis C in patients with very high serum alpha-fetoprotein levels and normal hepatic imaging.
Gonzalez SA; Jacobson IM
Am J Gastroenterol; 2005 Apr; 100(4):977-8. PubMed ID: 15784045
[No Abstract] [Full Text] [Related]
10. [The role of tumor markers in the diagnosis and follow-up of liver tumors].
Ottó S
Orv Hetil; 2004 Feb; 145(7 Suppl 1):385-7. PubMed ID: 15049057
[TBL] [Abstract][Full Text] [Related]
11. Alpha-2 macroglobulin: an additional marker for diagnosis of hepatocellular carcinoma.
Kar P; Gandhi BM; Irshad M; Gupta H; Tandon BN
J Assoc Physicians India; 1987 Apr; 35(4):288-9. PubMed ID: 2443479
[No Abstract] [Full Text] [Related]
12. [Surveillance of cirrhosis for hepatocellular carcinoma--clinical validation of new serological biomarkers for improved diagnosis].
Teofănescu I; Gologan E; Stefănescu G; Bălan G
Rev Med Chir Soc Med Nat Iasi; 2010; 114(1):39-46. PubMed ID: 20509274
[TBL] [Abstract][Full Text] [Related]
13. Significance of alpha-fetoprotein and des-gamma-carboxy prothrombin in patients with hepatocellular carcinoma undergoing hepatectomy.
Yamamoto K; Imamura H; Matsuyama Y; Hasegawa K; Beck Y; Sugawara Y; Makuuchi M; Kokudo N
Ann Surg Oncol; 2009 Oct; 16(10):2795-804. PubMed ID: 19669841
[TBL] [Abstract][Full Text] [Related]
14. [Focus on a new assay of fucosylated alpha-fetoprotein and evaluation in the biological diagnosis of hepatocellular carcinoma in cirrhosis].
Denis I; Beaudonnet A; Pichot J; Roubille M; Gelineau M
Ann Biol Clin (Paris); 2000; 58(1):85-90. PubMed ID: 10673618
[No Abstract] [Full Text] [Related]
15. Alpha-fetoprotein for hepatocellular carcinoma diagnosis: the demise of a brilliant star.
Forner A; Reig M; Bruix J
Gastroenterology; 2009 Jul; 137(1):26-9. PubMed ID: 19482098
[No Abstract] [Full Text] [Related]
16. [Biological markers of hepatocellular carcinoma].
Arfaoui D; Elloumi H; Ajmi S
Tunis Med; 2004 Apr; 82(4):329-34. PubMed ID: 15453027
[TBL] [Abstract][Full Text] [Related]
17. Alpha-fetoprotein and hepatocellular carcinoma.
Colli A; Fraquelli M; Conte D
Am J Gastroenterol; 2006 Aug; 101(8):1939; author reply 1940-1. PubMed ID: 16928257
[No Abstract] [Full Text] [Related]
18. Biomarkers for the early detection of cancer: an inflammatory concept.
Roy HK; Khandekar JD
Arch Intern Med; 2007 Sep; 167(17):1822-4. PubMed ID: 17893302
[No Abstract] [Full Text] [Related]
19. Marked episodic elevations of alpha-fetoprotein without hepatocellular carcinoma in a patient with hepatitis B.
Wong CB; Attar BM; Shimoda SS
Am J Gastroenterol; 1995 Jun; 90(6):1015-6. PubMed ID: 7539578
[No Abstract] [Full Text] [Related]
20. Glypican-3 as a serum marker for hepatocellular carcinoma.
Capurro M; Filmus J
Cancer Res; 2005 Jan; 65(1):372; author reply 372-3. PubMed ID: 15665316
[No Abstract] [Full Text] [Related]
[Next] [New Search]
